GENERIC MEDICINE SUPPLIER Teva Pharmaceuticals has announced a price reduction of more that 20 per cent across a wide range of its generic products, including seven of its top selling products.
The reduction is to take effect from next Thursday, 1 November.
Sandra Gannon, Teva’s general manager, confirmed that the company is prepared to cut its prices further if Government plans to introduce medicine reference pricing and generic substitution go ahead.
“This announcement reflects Teva’s commitment to reduce medicine prices for Irish consumers and to kick-start a radical shift away from the more expensive branded medicines to affordable generic alternatives,” Gannon said.
Teva medicines that will be subject to the price reductions include top-selling generic medicines such as Rosuvastatin, used to treat high cholesterol related conditions, Esomeprazole, used to treat stomach ulcers and Clopidogrel, used to prevent blood clotting.